市場調査レポート
商品コード
1168275
ヘルスケアにおけるロボティクス市場- テーマ別インテリジェンスRobotics in Healthcare - Thematic Intelligence |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ヘルスケアにおけるロボティクス市場- テーマ別インテリジェンス |
出版日: 2022年11月03日
発行: GlobalData
ページ情報: 英文 81 Pages
納期: 即納可能
|
医療機関は、スタッフ不足を補い、ケアの水準を向上させるために、医療ロボットへの投資を増やしていくとみられています。ヘルスケアにおけるロボティクスの市場規模は、2020年に47億米ドルとなりました。同市場は今後、12%のCAGRで拡大し、2030年には145億米ドルに達する見込みです。外科用ロボットは、整形外科用ロボットと神経外科用ロボットの売上増に後押しされ、同市場を牽引することになるとみられています。
当レポートでは、ヘルスケアにおけるロボティクス市場について調査し、市場の概要とともに、市場規模と成長予測、ロボティクスがヘルスケアに与える影響などを提供しています。
Macroeconomic factors will drive healthcare's use of robotics
The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.
Medical robots improve the standard of care
Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.
Double-digit growth is expected in the next decade
Robotics is a fast-growing industry. GlobalData expects every segment of the robotics market to grow over the next decade. According to GlobalData forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.
Industrial robots will enhance smart pharma manufacturing
The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, GlobalData's Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.